跳至主要内容
临床试验/NCT04947995
NCT04947995Unknown不适用

Validation of a Plasma-based Multiomics Assay and Risk Scoring Model for Screening of Gastric Malignancies

GeneCast Biotechnology Co., Ltd.1 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2021年6月15日最近更新:
适应症

试验速览

阶段
不适用
入组人数
450
试验地点
1
主要终点
The sensitivity and specificity of blood-based multi-omics assay for early detection of gastric cancer with comparison to EGD and/or histological diagnosis.

研究概览

简要总结

This is a prospective, case-control study intended to develop and validate a blood-based multi-omics assay and computational model for early detection of gastric cancer. Approximately 450 subjects who receive esophageogastroscopy (EGD) will be enrolled and assigned to three arms including gastric cancer, precancerous lesion, and healthy control based on the diagnosis of EGD and histological results. Cell free DNA will be extracted from peripheral blood of all participants and assayed by next-generation sequencing for biomarkers including somatic mutation, methylation, and chromosome instability signals. In the first stage a multi-omics models will be developed for classification between malignancy group and control groups, and between precancerous group and healthy control. Sensitivity and specificity of the model will be evaluated in an independent validation group in the second stage.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
40 Years 至 88 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Received EGD;
  • Subjects must have given written informed consent, and the subjects compliance are good.

排除标准

  • Subjects who could not accept EGD;
  • Subjects who had previously undergone total or partial gastrectomy;
  • There are other serious acute or chronic medical or mental diseases or laboratory abnormalities that may interfere with the interpretation of the research results and make the subjects unsuitable for the study in the judgment of the researchers;
  • Subjects with a history of malignant tumor or two or more malignant tumors at the same time;
  • Pregnant subjects;
  • Subjects who had a history of bone marrow or organ transplantation, or had a history of blood transfusion one month before enrollment.
  • The subjects with incomplete clinical data collection or other reasons judged by the researchers are not suitable for this study.

结局指标

主要结局

The sensitivity and specificity of blood-based multi-omics assay for early detection of gastric cancer with comparison to EGD and/or histological diagnosis.

时间窗: 24 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验